Ventria Bioscience Inc. v. Itc

Case: 23-1172 Document: 21 Page: 1 Filed: 03/14/2023

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

VENTRIA BIOSCIENCE INC.,

Appellant v.

INTERNATIONAL TRADE COMMISSION,

Appellee

WUHAN HEALTHGEN BIOTECHNOLOGY

CORPORATION,

Intervenor ______________________

2023-1172 ______________________

Appeal from the United States International Trade Commission in Investigation No. 337-TA-1238. ------------------------------------------------- WUHAN HEALTHGEN BIOTECHNOLOGY CORP.,

Appellant v.

INTERNATIONAL TRADE COMMISSION,

Appellee

VENTRIA BIOSCIENCE INC.,

Intervenor Case: 23-1172 Document: 21 Page: 2 Filed: 03/14/2023

2 WUHAN HEALTHGEN BIOTECHNOLOGY CORP. v. ITC

______________________

2023-1389 ______________________

Appeal from the United States International Trade Commission in Investigation No. 337-TA-1238 ______________________

ON MOTION ______________________

ORDER

Ventria Bioscience Inc. moves unopposed to voluntarily dismiss Appeal No. 2023-1172 pursuant to Federal Rule of Appellate Procedure 42(b) and the parties’ agreement as to the allocation of costs.

Upon consideration thereof,

IT IS ORDERED THAT: (1) The motion is granted. Appeal No. 2023-1172 is dismissed. (2) Each party shall bear its own costs for Appeal No. 2023-1172. (3) The revised official caption for Appeal No. 2023- 1389 is reflected in this order. (4) Wuhan Healthgen Biotechnology Corp.’s opening brief in Appeal No. 2023-1389 is due no later than 60 days Case: 23-1172 Document: 21 Page: 3 Filed: 03/14/2023

WUHAN HEALTHGEN BIOTECHNOLOGY CORP. v. ITC 3 from the date of filing of this order.

FOR THE COURT March 14, 2023 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

ISSUED AS A MANDATE (for 2023-1172 only): March 14, 2023